Swiss Life: UBS maintains 'buy' rating, raises target price
(CercleFinance.com) - UBS reiterates its “buy” recommendation on the share of Swiss Life Holdings, with a higher target of 470 Swiss francs (vs.
44 Swiss francs), which represents upside potential of over 6% for the Swiss insurance group's share relative to its current price.
"The shares have had a great run, but we still find scope for further multiple expansion in time," the broker explains in its report on the share.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
44 Swiss francs), which represents upside potential of over 6% for the Swiss insurance group's share relative to its current price.
"The shares have had a great run, but we still find scope for further multiple expansion in time," the broker explains in its report on the share.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.